Clinical Trial Update: European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin Alfa

View source ↗

Summary

An EU pediatric registry study evaluating safety and usage patterns of darbepoetin alfa in chronic kidney disease. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Chronic Kidney Disease | Status: COMPLETED | Results posted: 2014-07-09